MAPT and Alzheimer disease: Calproteinase-mediated hydrolysis of cyclin-associated activating molecule p35 to p25 leads to dislocation of CDK-5, and then forms a stable complex with highly phosphorylated Tau protein, increasing the pathology of AD.